Home/Filings/4/0001104659-20-132538
4//SEC Filing

Rajah Vignesh 4

Accession 0001104659-20-132538

CIK 0001722964other

Filed

Dec 3, 7:00 PM ET

Accepted

Dec 4, 6:00 PM ET

Size

6.7 KB

Accession

0001104659-20-132538

Insider Transaction Report

Form 4
Period: 2020-11-17
Rajah Vignesh
SVP and CMO
Transactions
  • Purchase

    Common Stock

    2020-12-02$51.03/sh+233$11,8901,697 total(indirect: By Children)
  • Purchase

    Common Stock

    2020-11-17$45.74/sh+1,464$66,9631,464 total(indirect: By Spouse)
Footnotes (2)
  • [F1]Reporting Person may be deemed to have a pecuniary interest in the securities due to family relationship.
  • [F2]Reporting Person disclaims beneficial ownership of the securities reported and this report shall not be deemed an admission that Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act, as amended, or for any other purpose.

Documents

1 file

Issuer

Y-mAbs Therapeutics, Inc.

CIK 0001722964

Entity typeother

Related Parties

1
  • filerCIK 0001815042

Filing Metadata

Form type
4
Filed
Dec 3, 7:00 PM ET
Accepted
Dec 4, 6:00 PM ET
Size
6.7 KB